ATE429433T1 - Herstellungsverfahren für moxifloxacin und moxifloxacinhydrochlorid - Google Patents

Herstellungsverfahren für moxifloxacin und moxifloxacinhydrochlorid

Info

Publication number
ATE429433T1
ATE429433T1 AT07103405T AT07103405T ATE429433T1 AT E429433 T1 ATE429433 T1 AT E429433T1 AT 07103405 T AT07103405 T AT 07103405T AT 07103405 T AT07103405 T AT 07103405T AT E429433 T1 ATE429433 T1 AT E429433T1
Authority
AT
Austria
Prior art keywords
moxifloxacin
pot
production process
hydrochloride
avoids
Prior art date
Application number
AT07103405T
Other languages
English (en)
Inventor
Nicolau Francisco Palomo
Gomez Antonio Cosme
Prieto Javier Villasante
Llorca Sara Penelope Fernandez
Ponce Andres Molina
Original Assignee
Sint Quimica Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sint Quimica Sa filed Critical Sint Quimica Sa
Application granted granted Critical
Publication of ATE429433T1 publication Critical patent/ATE429433T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
AT07103405T 2006-03-10 2007-03-02 Herstellungsverfahren für moxifloxacin und moxifloxacinhydrochlorid ATE429433T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200600608A ES2284380B1 (es) 2006-03-10 2006-03-10 Procedimiento para la preparacion de moxifloxacino y moxifloxacino clorhidrato.

Publications (1)

Publication Number Publication Date
ATE429433T1 true ATE429433T1 (de) 2009-05-15

Family

ID=38042667

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07103405T ATE429433T1 (de) 2006-03-10 2007-03-02 Herstellungsverfahren für moxifloxacin und moxifloxacinhydrochlorid

Country Status (7)

Country Link
EP (1) EP1832587B1 (de)
AT (1) ATE429433T1 (de)
DE (1) DE602007000930D1 (de)
DK (1) DK1832587T3 (de)
ES (2) ES2284380B1 (de)
PL (1) PL1832587T3 (de)
PT (1) PT1832587E (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0612422D0 (en) * 2006-06-23 2006-08-02 Generics Uk Ltd Novel hydrate form
NZ576929A (en) 2006-11-13 2012-07-27 Cipla Ltd Crystalline anhydrous form C of moxifloxacin hydrochloride
ES2311391B1 (es) * 2007-02-07 2009-12-22 Quimica Sintetica, S.A. Forma cristalina de moxifloxacino base.
IT1393337B1 (it) 2009-03-06 2012-04-20 Italiana Sint Spa Sintesi di (4as, 7as)-ottaidro-1h-pirrolo[3,4-b]piridina
CN102617622B (zh) * 2011-01-31 2016-06-15 深圳信立泰药业股份有限公司 一种制备莫西沙星或其可药用盐及其中间体的方法
ITTO20110705A1 (it) 2011-07-29 2013-01-30 Italiana Sint Spa Procedimento di preparazione della moxifloxacina cloridrato e relativi intermedi
CN102603738B (zh) * 2012-02-24 2013-12-11 天津市汉康医药生物技术有限公司 一种稳定的盐酸莫西沙星化合物
CN102924449B (zh) * 2012-10-30 2015-08-12 重庆福安药业集团庆余堂制药有限公司 盐酸莫西沙星h晶型及其制备方法和药物组合物
CA2893534A1 (en) * 2012-12-04 2014-06-12 Mankind Research Centre An improved process for the preparation of moxifloxacin hydrochloride
CN104098561B (zh) * 2013-04-10 2016-01-20 山东省生物医药科学院 一种适合工业化生产的制备高光学纯度盐酸莫西沙星的方法
CN103965189B (zh) * 2013-12-30 2015-09-09 西安万隆制药股份有限公司 一种新的盐酸莫西沙星化合物
CN112759590B (zh) * 2020-11-19 2021-12-31 内蒙古源宏精细化工有限公司 一种莫西沙星的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95130C (fi) * 1988-07-20 1995-12-27 Sankyo Co Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi
ES2017864A6 (es) * 1989-11-29 1991-03-01 Marga Investigacion Procedimiento para la preparacion de n-ciclopropilquinolonas.
TW209865B (de) * 1992-01-10 1993-07-21 Bayer Ag
ES2077490B1 (es) * 1992-11-18 1996-10-16 Marga Investigacion Esteres trimetilsililicos y solvatos de quelatos de acidos quinolin-3-carboxilicos. preparacion y aplicacion al proceso de quinolonas.
CA2521398C (en) * 2003-04-09 2011-03-22 Dr. Reddy's Laboratories Limited A crystalline form iii of anhydrous moxifloxacin hydrochloride and a process for preparation thereof
WO2005012285A1 (en) * 2003-08-05 2005-02-10 Matrix Laboratories Ltd An improved process for the preparation of moxifloxacin hydrochloride
ES2232309B1 (es) * 2003-11-13 2006-08-01 Quimica Sintetica, S.A. Procedimiento simplificado para la obtencion de gatifloxacino.

Also Published As

Publication number Publication date
ES2284380A1 (es) 2007-11-01
PT1832587E (pt) 2009-07-10
ES2324923T3 (es) 2009-08-19
EP1832587B1 (de) 2009-04-22
ES2284380B1 (es) 2008-11-01
EP1832587A1 (de) 2007-09-12
PL1832587T3 (pl) 2010-01-29
DK1832587T3 (da) 2009-08-10
DE602007000930D1 (de) 2009-06-04

Similar Documents

Publication Publication Date Title
DE602007000930D1 (de) Herstellungsverfahren für Moxifloxacin und Moxifloxacinhydrochlorid
ZA202407520B (en) Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
MX2009004351A (es) Anticuerpos anti-htnfalfa cristalinos.
DE602007006765D1 (de) Herstellungsverfahren für optisch aktive chirale amine
EP2407457A4 (de) Verfahren zur herstellung eines diaminderivats
EP2508655A4 (de) Verfahren zur herstellung eines siliciumcarbideinzelkristalls
MY201120A (en) Intermediates for use in a process of producing pyrrole compounds
PT2408739E (pt) Um processo para a preparação de 6-(7-((1-aminociclopropil) metoxi)-6-metoxiquinolin-4-iloxi)-n-metil-1-naftamida e seus intermediários sintéticos
BRPI0519624B8 (pt) processo para preparação de ansamitocinas purificadas
MX377930B (es) Proceso para fabricar compuestos de quinolona.
ATE517869T1 (de) Herstellung substituierter morphinan-6-one und salzen und zwischenprodukten davon
MA31325B1 (fr) Nouveaux procedes
WO2011114210A3 (en) Processes for the preparation of linezolid
DK2204383T3 (da) Fremgangsmåde til fremstilling af eptifibatid og relevante mellemproduktforbindelser
WO2014115174A3 (en) Novel approach for synthesis of catechins
SG158885A1 (en) Synthesis of himbacine analogs
MX2018010128A (es) Toxina nueva y metodo de preparacion de un intermediario de la misma.
FR2854402B1 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroides
WO2010012797A3 (en) Synthesis of 3,4-diaryl-4,5-dihydro-(1h)-pyrazole-1- carboxamidine derivatives
WO2007010412A3 (en) Syntheses and preparations of narwedine and related novel compounds
MY147894A (en) Process for preparing intermediate compound for synthesizing an antiulcerant
EP2130827A4 (de) Verfahren zur herstellung eines chinolon-carboxylsäure-derivats
WO2012070896A3 (en) Synthetic method of enantiomerically pure 2,2'-dihydroxy-1,1'-binaphthyl-3-carboxylic acid
WO2007015259A3 (en) Method of synthesizing key intermediates for the production of camptothecin derivatives
ATE540955T1 (de) Herstellungsprozess für galantaminhydrobromid

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification

Ref document number: 1832587

Country of ref document: EP